Cargando…
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study
Antiplatelet therapy with clopidogrel has been shown to reduce major adverse cardiac events in acute coronary syndromes and after percutaneous interventions. This effect is not only due to its anti-platelet effect but also possibly due to an anti-inflammatory effect. The effect of clopidogrel cessat...
Autores principales: | Wykrzykowska, Joanna J., Warnholtz, Ascan, de Jaeger, Peter, Curzen, Nick, Oldroyd, Keith G., Collet, Jean Philippe, Ten Berg, Jurrien M., Rademaker, Tessa, Goedhart, Dick, Lissens, Jurgen, Kint, Peter-Paul, Serruys, Patrick W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766044/ https://www.ncbi.nlm.nih.gov/pubmed/19504052 http://dx.doi.org/10.1007/s11239-009-0354-y |
Ejemplares similares
-
Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers
por: Decker, Carole, et al.
Publicado: (2008) -
Clopidogrel Therapy Discontinuation Following Drug Eluting Stent Implantation in Real World Practice in Israel
por: Blich, Miry, et al.
Publicado: (2012) -
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study
por: Thim, Troels, et al.
Publicado: (2014) -
Hospital Variation in Premature Clopidogrel Discontinuation After Drug‐Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System
por: Vigen, Rebecca, et al.
Publicado: (2016) -
A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting Stent Implantation
por: Park, Yae Min, et al.
Publicado: (2012)